A retrospective study to evaluate the efficacy and safety of carbon ion radiation therapy for primary lung cancer.

A retrospective study to evaluate the efficacy and safety of carbon ion radiation therapy for primary lung cancer. - A retrospective study of carbon ion radiation therapy for primary lung cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052389

Enrollment

150

Registered

2023-10-03

Start date

2023-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients treated with carbon ion radiation therapy for primary lung cancer at QST Hospital from April 1994 to March 2025

Exclusion criteria

Exclusion criteria: Refusal by the patient

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Adverse events, local control, recurrence-free survival, respiratory function preservation rate	—

Countries

Japan

Contacts

Public ContactShuri Aoki

National institutes for Quatum Science and Technology QST Hospital Division of Treatment and Diagnosis

aoki.shuri@qst.go.jp0432063306

Outcome results